Client reviews
KEY CLIENTS
The teams that
trust Thelansis
Pharmaceutical, biotech and medical device companies, and the investors behind them, rely on our evidence to make their next move.
- Santen Pharma
- Vicore Pharma
- Newron
- Stemline Therapeutics
- Camurus
- Sanquin
- WEX Therapeutics
- Reata Pharmaceuticals
- Asarina Pharma
- Acadia Pharmaceuticals
10+
Years in life sciences research
1M+
Research hours
6,000+
Reports delivered
8,500+
Physicians in our expert panel
Case studies
See the work
behind the results
Read how we’ve helped teams size markets, forecast launches, and plan access.
Who we serve
Built for teams like yours
Emerging biotech
Prove the opportunity before you raise or partner
Pharmaceutical, biotech and medical device companies, and the investors behind them, rely on our evidence to make their next move.
Small and mid-cap pharma
Put your resources behind the right assets
Rank pipeline options, plan launches and test your assumptions with the physicians who will prescribe.
Large and multinational pharma
Keep every market and indication in view
Track epidemiology, treatment patterns and access conditions across countries and therapy areas.
Medical device
Find the patients and payers your device needs
Size the population you can address, understand who pays, and build the value story behind your device.
Investment firms
Back assets with independent evidence
Test a target’s market, competition and pipeline before you commit capital.
Ask for a demo
Become our next success story
Tell us what you’re working on. We’ll reply within one business day.
More about Thelansis
What makes us a different partner
What makes us a different partner
Why we do what we do
Our Team
Meet the people behind the insight
More
More
- Report & Insights
- Strategy Products
Strategy Products
- Consulting Services
- Media
Media
